FDA allows temporary import of unapproved Chinese cancer drug to ease U.S. shortage
Worker labors on a production line at factory of Qilu Pharmaceutical (Hainan) Co Ltd on February 11, 2022 in Haikou, Hainan Province of China.Su Bikun | VCG | Getty ImagesThe Food and Drug Administration has authorized the temporary…